{"task_id": "e842cc2666c32bc1", "source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 126/464)", "text": "clinician\nor computer model\n2.2\n0.45\nDyspepsia\n113\n\n--- Page 135 ---\nCLINICAL FEATURES (CONT\u2019D)\nPRACTICAL APPROACH TO DYSPEPSIA\n1. Consider non gastric causes of dyspepsia (car\ndiac, pulmonary, hepatobiliary, colonic, musculos\nkeletal, medications, and dietary indiscretion) and\ninvestigate those causes if likely. Otherwise pro\nceed to step 2\n2. If age >50 or alarm symptoms HVery BADH\n(Vomiting,\nBleed/anemia,\nAbdominal\nmass/\nweight loss, Dysphagia), refer for gastroscopy to\ncheck for gastric cancer. Otherwise proceed to\nstep 3\n3. If ASA or NSAIDs use, stop medications if possible.\nIf not, consider proton pump inhibitor/H2 blocker\ntrial and proceed to step 4\n4. If GERD predominant symptoms (heartburn,\nregurgitation), treat as GERD. Otherwise, proceed\nto step 5\n5. If H. pylori urea breath test positive, treat with\ntriple therapy. Otherwise, proceed to step 6\n6. If none of the above, diagnosis of non ulcer\ndyspepsia\nCanadian Dyspepsia Working Group. Can J\nGastroenterol 2005 19:5\nINVESTIGATIONS\nBASIC\n\u0002\nLABS\nCBCD, lytes, glucose, AST, ALT, ALP,\nbilirubin, lipase, Ca, albumin, fecal occult\nblood\n\u0002\nIMAGING\nupper GI series, U/S abd, CT abd\nSPECIAL\n\u0002\nUREA BREATH TEST\n\u0002 H. PYLORI SEROLOGY\n\u0002 24-H ESOPHAGEAL PH MONITORING\n\u0002\nENDOSCOPY WITH BIOPSY\nurease test, C&S for\nH. pylori\n\u0002\nPROTON\nPUMP\nINHIBITOR\nTEST\nsens 78% for\nGERD\nMANAGEMENT\nPEPTIC ULCER DISEASE\navoid NSAID use. Anti\nsecretory treatment (ranitidine 150 300 mg PO BID,\nomeprazole\n20 40\nmg\nPO\ndaily,\nlansoprazole\n15 30 mg PO daily, pantoprazole 40 mg PO BID). H.\npylori eradication (HCAOH: clarithromycin 500 mg\nPO BID, amoxicillin 1 g PO BID, omeprazole 40 mg PO\ndaily \u000410 days; HCMOH (if penicillin allergy): clari\nthromycin 500 mg PO BID, metronidazole 250 mg PO\nQID, omeprazole 40 mg PO daily \u000410 days; HBMTH\n(if macrolide allergy or failed first line): bismuth 30 mL\nPO QID, metronidazole 250 mg PO QID, tetracycline\n500 mg PO QID \u00042 weeks)\nGERD\nlifestyle changes (avoid coffee, alcohol,\nchocolate, high fat meals, acidic or spicy foods.\nMore frequent, smaller portions, weight loss, smoking\ncessation, elevate bed, loose garments). Antisecre\ntory treatment (proton pump inhibitors more effec\ntive than H2 blockers for esophagitis. Use antacids as\nbreakthrough). Nissen fundoplication\nNON ULCER\nDYSPEPSIA\nlifestyle\nchanges\n(avoid alcohol, caffeine, tobacco). Antisecretory\ntreatment (see above). H. pylori eradication\n(may or may not relieve symptoms). Promotility\nagent (domperidone)\nRelated Topics\nEsophageal Cancer (p. 195)\nGastric Cancer (p. 197)\nGastric Lymphoma (p. 173)\nSPECIFIC ENTITIES\nGERD\n\u0002\nCAUSES\nobesity, lower esophageal sphincter pres\nsure, decreased esophageal peristalsis, gastric acid\nhypersecretion, delayed gastric emptying, and\novereating\n\u0002\nPATHOPHYSIOLOGY\nreflux of stomach contents, lead\ning to a multitude of symptoms including heartburn,\nregurgitation, dysphagia, chest pain, complicated by\nesophagitis, esophageal stricture, Barrett\u2019s esopha\ngus, and esophageal adenocarcinoma\n\u0002\nCLINICAL FEATURES\nesophageal (heartburn, regur\ngitation), extra esophageal (wheeze, cough, pneu\nmonia, waterbrash, hoarseness, sore throat, glo\nbus, dental erosions)\n\u0002\nDIAGNOSIS\nclinical based on symptoms (\u00052/week).\nEndoscopy to look for complications and rule out\nother potential diagnoses\nNEJM 2008 359:16\nNSAIDS INDUCED GASTROPATHY\n\u0002\nPATHOPHYSIOLOGY\nNSAIDs inhibit COX 1 (nor\nmally protective effect through mucus secretion,\nLR+\nLR\nEsophagitis\nDiagnosis reached by the clinician\nor computer model\n2.4\n0.5\nAPPROACH\n\u2018\u2018functional dyspepsia is defined\nas pain or discomfort centered in the epigas\ntrium with a normal endoscopy. Neither clinical\nimpression nor computer models that incorpo\nrated patient demographics, risk factors, history\nitems and symptoms adequately distinguished\nbetween\norganic\nand\nfunctional\ndisease\nin\npatients referred for endoscopic evaluation of\ndyspepsia\u2019\u2019\nJAMA 2006 295:13\n114\nDyspepsia", "text_length": 3889, "metadata": {"source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 126/464)", "type": "chunk", "chunk_index": 125, "total_chunks": 464, "uploaded_by": "admin@admin.com", "upload_date": "2025-12-11T18:40:09.417437", "document_uuid": "fda2cab4-cdd9-4015-af24-46fd62c86d94", "filename": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf", "category": "medical_pdf", "section": "body", "year": null, "outdated": false, "document_id": "fda2cab4-cdd9-4015-af24-46fd62c86d94"}, "created_at": "2025-12-11T18:40:09.418363", "status": "complete", "chunks_added": 2}